Justyna Kelly - Dec 9, 2021 Form 4 Insider Report for POINT Biopharma Global Inc. (PNT)

Role
Chief Operating Officer
Signature
/s/ William L. Demers, by Power of Attorney for Justyna Kelly
Stock symbol
PNT
Transactions as of
Dec 9, 2021
Transactions value $
$0
Form type
4
Date filed
12/10/2021, 10:27 AM
Previous filing
Dec 10, 2021
Next filing
Mar 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PNT Stock Option (Right to Buy) Award $0 +70K $0.00 70K Dec 9, 2021 Common Stock 70K $6.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on December 9, 2022 with the remaining 75% vesting in three equal annual installments thereafter. Notwithstanding the foregoing, upon any Sale Event (as defined in the Issuer's 2021 Plan), any outstanding stock options shall automatically become fully vested and exercisable as of the effective time of the Sale Event.